English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1983]
News [3212]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Stem cell study offers clues for optimising bone marrow transplants and more
Stem cell study offers clues for optimising bone marrow transplants and more
An errant editing enzyme promotes tumour suppressor loss and leukaemia propagation
An errant editing enzyme promotes tumour suppressor loss and leukaemia propagation
Study finds elevated risk of rare blood cancers after chemotherapy for most solid tumours
Study finds elevated risk of rare blood cancers after chemotherapy for most solid tumours
From eye drops to potential leukaemia treatment
From eye drops to potential leukaemia treatment
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
Myeloma XI: Quadruplet regimen for transplant eligible patients shows promise
Myeloma XI: Quadruplet regimen for transplant eligible patients shows promise
Cancer patients face higher risk for shingles, new vaccines hold promise for prevention
Cancer patients face higher risk for shingles, new vaccines hold promise for prevention
Some brain tumours may respond to immunotherapy, new study suggests
Some brain tumours may respond to immunotherapy, new study suggests
ASH 2018: Cancer patients show reduced risk of harmful clots while taking direct oral anticoagulants
ASH 2018: Cancer patients show reduced risk of harmful clots while taking direct oral anticoagulants
ASH 2018: Ibrutinib-based therapy more effective, safer in younger patients with previously untreated CLL compared with current standard of care
ASH 2018: Ibrutinib-based therapy more effective, safer in younger patients with previously untreated CLL compared...
<1...117118119120121...322>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top